Various studies have reported divergent results regarding the AMH level in BRCA1/2-mutated and non-mutated carriers diagnosed with BC or healthy (non-) carriers [68,94,95,96,98,99,100,101,102,103,104,105,107,108,148]. The gene discussed is AMH; the disease is breast cancer.